These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33584730)

  • 1. Elevated Circulating IL-10 Producing Breg, but Not Regulatory B Cell Levels, Restrain Antibody-Mediated Rejection After Kidney Transplantation.
    Luo Y; Luo F; Zhang K; Wang S; Zhang H; Yang X; Shang W; Wang J; Wang Z; Pang X; Feng Y; Liu L; Xie H; Feng G; Li J
    Front Immunol; 2020; 11():627496. PubMed ID: 33584730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitional immature regulatory B cells and regulatory cytokines can discriminate chronic antibody-mediated rejection from stable graft function.
    Salehi S; Shahi A; Afzali S; Keshtkar AA; Farashi Bonab S; Soleymanian T; Ansaripour B; Amirzargar AA
    Int Immunopharmacol; 2020 Sep; 86():106750. PubMed ID: 32652501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and functional alterations of regulatory B cell subsets in adult allergic asthma patients.
    Wiest M; Upchurch K; Hasan MM; Cardenas J; Lanier B; Millard M; Turner J; Oh S; Joo H
    Clin Exp Allergy; 2019 Sep; 49(9):1214-1224. PubMed ID: 31132180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Tim-1 and IL-10 Expression in Regulatory B Cell Subsets in Type 1 Diabetes.
    Liu Y; Chen Z; Qiu J; Chen H; Zhou Z
    Front Immunol; 2021; 12():773896. PubMed ID: 35754999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
    Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
    Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance favoring follicular helper T cells over IL10
    Laguna-Goya R; Utrero-Rico A; Cano-Romero FL; Gómez-Massa E; González E; Andrés A; Mancebo-Sierra E; Paz-Artal E
    Kidney Int; 2020 Sep; 98(3):732-743. PubMed ID: 32495741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Transplant Recipients Treated with Calcineurin-Inhibitors Lack Circulating Immature Transitional CD19+CD24hiCD38hi Regulatory B-Lymphocytes.
    Tebbe B; Wilde B; Ye Z; Wang J; Wang X; Jian F; Dolff S; Schedlowski M; Hoyer PF; Kribben A; Witzke O; Hoerning A
    PLoS One; 2016; 11(4):e0153170. PubMed ID: 27045291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbes enlarged the protective effect of transplanted regulatory B cells on rejection of cardiac allografts.
    Li W; Wang D; Yue R; Chen X; Liu A; Xu H; Teng P; Wang Z; Zou Y; Xu X; Zhao H; Li R; Fu Y; Guo L; Ni C; Fan J; Ma L
    J Heart Lung Transplant; 2021 Dec; 40(12):1502-1516. PubMed ID: 34742645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human regulatory B cells in health and disease: therapeutic potential.
    Mauri C; Menon M
    J Clin Invest; 2017 Mar; 127(3):772-779. PubMed ID: 28248202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.
    Fidler S; Swaminathan R; Lim W; Ferrari P; Witt C; Christiansen FT; D'Orsogna LJ; Irish AB
    Transpl Immunol; 2013 Dec; 29(1-4):22-7. PubMed ID: 24090807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.
    Eskandary F; Bond G; Kozakowski N; Regele H; Marinova L; Wahrmann M; Kikić Ž; Haslacher H; Rasoul-Rockenschaub S; Kaltenecker CC; König F; Hidalgo LG; Oberbauer R; Halloran PF; Böhmig GA
    Transplantation; 2017 Mar; 101(3):631-641. PubMed ID: 27120452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the Subsets of IL-10-Producing Regulatory B Cells in the Course of Tolerance Induction and Maintenance in Islet Allotransplantation.
    Li S; Li X; Yang M; Wei L; Wei L; Deng S; Zhao G
    Transplant Proc; 2018 Dec; 50(10):3900-3905. PubMed ID: 30577284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating angiotensin type II receptor: Possible marker for antibody mediated rejection after renal transplantation?
    Kimball PM; Gupta G; McDougan F
    Hum Immunol; 2017 Oct; 78(10):629-633. PubMed ID: 28614703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory B cells: Phenotype, function and role in transplantation.
    Wortel CM; Heidt S
    Transpl Immunol; 2017 Mar; 41():1-9. PubMed ID: 28257995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical Antibody-mediated Rejection After Kidney Transplantation: Treatment Outcomes.
    Parajuli S; Joachim E; Alagusundaramoorthy S; Blazel J; Aziz F; Garg N; Muth B; Mohamed M; Mandelbrot D; Zhong W; Djamali A
    Transplantation; 2019 Aug; 103(8):1722-1729. PubMed ID: 30507740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble BAFF Cytokine Levels and Antibody-Mediated Rejection of the Kidney Allograft.
    Slavcev A; Brozova J; Slatinska J; Sekerkova Z; Honsova E; Skibova J; Striz I; Viklicky O
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):47-53. PubMed ID: 28083608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher CD19+CD25
    Ibrahim EH; Aly MG; Opelz G; Morath C; Zeier M; Süsal C; Sayed DM; Hassan E; Ekpoom N; Daniel V
    BMC Nephrol; 2021 May; 22(1):180. PubMed ID: 33993874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-27-producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases.
    Choi JK; Yu CR; Bing SJ; Jittayasothorn Y; Mattapallil MJ; Kang M; Park SB; Lee HS; Dong L; Shi G; Caspi RR; Egwuagu CE
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.